Shaw, R., Yoon, J. J., Johnston, H., Davidson, M. B., Siddon, A. J., Shallis, R. M., Chen, E. C., Burkart, M., Oh, T. S., Iyer, S. G., Madarang, E., Muthiah, C., Kassner, J., Rampal, R. K., Guru Murthy, G. S., Bradley, T. J., Abaza, Y., Garcia, J. S., Gupta, V., … Patel, A. A. (2025). Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy. Blood Advances. https://doi.org/10.1182/bloodadvances.2024015712
Subjects:
Molecular Pathogenesis of Myeloproliferative Disorders
(OpenAlex Topic)
Idiopathic Pulmonary Fibrosis: Diagnosis and Management
(OpenAlex Topic)
Acute Myeloid Leukemia
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2024015712
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: